Source: Annual Congress 2009 - Pathogenesis of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
P. Souza, F. Rizzardi, G. Noleto, M. Atanazio, O. Bianchi, E. R. Parra, W. Teodoro, W. Souza, L. Antonangelo, A. Ab‘Saber, T. Takagaki, J. Das Neves, N. Yoshinari, V. Capelozzi (São Paulo, Brazil). Refractory remodelling of the microenvironment by type V collagen and apoptosis in non small cell lung cancer. Eur Respir J 2009; 34: Suppl. 53, 4204

Member's Comments

No comment yet.

Related content which might interest you: Type V collagen and endothelial apoptosis interface in non small cell lung cancer has impact on prognosis Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Down regulation of type V collagen triggers angiogenesis and immune response disfunction in lung cancer microenvironment Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010 PP126 – RANKL contributes to lung tissue repair via promoting type II epithelial cell proliferation Source: ERS Lung Science Conference 2021 Year: 2021 RANKL contributes to lung tissue repair via promoting type II epithelial cell proliferation Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020 Nasal tolerance promotes increase in tumoral type V collagen protein synthesis and vascular apoptosis in the mouse lung chemical carcinogenesis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 The role of cell lines in modelling the type II pneumocyte in interstitial lung disease Source: Virtual Congress 2020 – Human ex vivo models of interstitial lung disease Year: 2020 Aging causes alveolar epithelial type II cell dysfunction in acute lung injury Source: ERS Lung Science Conference 2020 Year: 2020 Differential effects of collagen I and III and vitronectin on proliferation and apoptosis of human lung fibroblasts Source: Eur Respir J 2004; 24: Suppl. 48, 105s Year: 2004 Epithelial cell matrix proteins and lymphocyte activation genes in COPD and lung cancer Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Decreased VEGF concentration in lung tissue and vascular injury during ARDS Source: Eur Respir J 2005; 25: 139-146 Year: 2005 The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair Source: Eur Respir J 2004; 24 : 664-673 Year: 2004 HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Bleomycin induces cellular senescence in alveolar epithelial cells Source: Eur Respir J 2003; 22: 436-443 Year: 2003 Induction of mesenchymal cell phenotypes in lung epithelial cells by adenovirus E1A Source: Eur Respir J 2006; 28: 1106-1117 Year: 2006 Apoptosis and non-apoptotic cell death induced by mechanical stress in alveolar type II cells and pulmonary microvascular endothelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 587s Year: 2003 Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling. Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Cellular matrix and proliferation proteins in COPD and lung cancer Source: Annual Congress 2008 - Airway infection and host defence Year: 2008 IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer Source: Eur Respir J , 49 (4)  1600711; DOI: 10.1183/13993003.00711-2016 Year: 2017 Ex vivo trans-differentiation of primary human alveolar epithelial cells type II by TGFb Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014